After a brief introduction, Nathan L. Scott, M.D., gives an overview of uveal melanoma, including the risk factors and ways to help prevent it. This program was made possible with support from ...
MedPage Today on MSN
Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma
Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...
Adding the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab to percutaneous hepatic perfusion may improve survival outcomes in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results